4-(5-Benzyl-3-((4-fluorophenyl)sulfonyl)-5-methyl-4,5-dihydrofuran-2-yl)-2-nitrobenzamide

4-(5-Benzyl-3-((4-fluorophenyl)sulfonyl)-5-methyl-4,5-dihydrofuran-2-yl)-2-nitrobenzamide

As part of our ongoing attempt to broaden the applications of the amidoxime moiety as a potential source of new antileishmanial agents, this study focuses on the product 4-(5-Benzyl-3-((4-fluorophenyl)sulfonyl)-5-methyl-4,5-dihydrofuran-2-yl)-2-nitrobenzamide. This unexpected amide was obtained in a...

Full description

Bibliographic Details
Main Authors: Oscar Leonardo Avendaño Leon, Christophe Curti, Hussein El-Kashef, Youssef Kabri, Sébastien Redon, Patrice Vanelle
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Molbank
Subjects:
amidoxime
amide
4,5-dihydrofuran
nitro group
leishmania
Online Access:https://www.mdpi.com/1422-8599/2023/4/M1750

Internet

https://www.mdpi.com/1422-8599/2023/4/M1750

Similar Items